click tracking
Swiss Life Sciences Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 101 - 120 out of 235 displayed.
«  1  2  3  4  5 6  7  8  9  10  11  12 »

Auris Medical Announces Receipt of Nasdaq Notice

Read more ››
By: Nasdaq / GlobenewsWire - 08 Feb 2019
Related companies:  Auris Medical Holding AG

Strong European Cresemba® (isavuconazole) sales trigger USD 5 million milestone payment to Basilea from Pfizer

Read more ››
By: Nasdaq / GlobenewsWire - 08 Feb 2019
Related companies:  Basilea Pharmaceutica Ltd | Basilea Pharmaceutica Deutschland GmbH

Myovant Provides Corporate Updates and Reports Financial Results for Third Fiscal Quarter Ended December 31, 2018

BASEL, Switzerland, Feb. 7, 2019 /PRNewswire/ -- Myovant Sciences (NYSE: MYOV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of women's health and endocrine diseases, today announced corporate updates and reported... Read more ››

By: PR Newswire Association LLC. - 07 Feb 2019
Related companies:  Myovant Sciences GmbH

Basilea announces change in the Management Committee - Adesh Kaul appointed CFO

Read more ››
By: Nasdaq / GlobenewsWire - 07 Feb 2019
Related companies:  Basilea Pharmaceutica Ltd | Basilea Pharmaceutica Deutschland GmbH

Sanofi delivers 2018 business EPS growth of 5.1% at CER

Read more ››
By: Nasdaq / GlobenewsWire - 07 Feb 2019

Sanofi's Board of Directors notes the resignation of Christian Mulliez and co-opts Christophe Babule as Director

Read more ››
By: Nasdaq / GlobenewsWire - 06 Feb 2019

Sanofi: FDA approves Cablivi® (caplacizumab-yhdp), the first Nanobody®-based medicine, for adults with acquired thrombotic thrombocytopenic purpura (aTTP)

Read more ››
By: Nasdaq / GlobenewsWire - 06 Feb 2019

Lundbeck realized 8% growth in revenue (local currencies) and 48% growth in EPS in 2018

Read more ››
By: Nasdaq / GlobenewsWire - 05 Feb 2019

Annual Report 2018 for H.Lundbeck A/S

Read more ››
By: Nasdaq / GlobenewsWire - 05 Feb 2019

Novo Nordisk files annual report with the SEC

Read more ››
By: Nasdaq / GlobenewsWire - 05 Feb 2019

Sanofi : Isatuximab Phase 3 trial meets primary endpoint of prolonging progression free survival in patients with relapsed/refractory multiple myeloma

Read more ››
By: Nasdaq / GlobenewsWire - 05 Feb 2019

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 1 February 2019

Read more ››
By: Nasdaq / GlobenewsWire - 04 Feb 2019

Enzyvant to Highlight Investigational RVT-801 Program and Farber Disease Natural History Study at Upcoming WORLDSymposium(TM)

BASEL, Switzerland and CAMBRIDGE, Mass., Feb. 4, 2019 /PRNewswire/ -- Enzyvant, a biopharmaceutical company focused on developing transformative therapies for patients with rare diseases, today announced that abstracts highlighting the development of its investigational RVT-801 program and the... Read more ››

By: PR Newswire Association LLC. - 04 Feb 2019
Related companies:  Enzyvant GmbH

Sanofi: CHMP recommends approval of Praluent® (alirocumab) to reduce cardiovascular risk in people with established atherosclerotic cardiovascular disease

Read more ››
By: Nasdaq / GlobenewsWire - 04 Feb 2019

Auris Medical Announces Full Repayment of Hercules Loan Facility

Read more ››
By: Nasdaq / GlobenewsWire - 01 Feb 2019
Related companies:  Auris Medical Holding AG

Novo Nordisk's operating profit decreased by 4% in Danish kroner and increased by 3% in local currencies in 2018

Read more ››
By: Nasdaq / GlobenewsWire - 01 Feb 2019

Novo Nordisk A/S - Share repurchase programme

Read more ››
By: Nasdaq / GlobenewsWire - 31 Jan 2019

MBP Solutions Takes Lead in UN Global Compact Climate Change Sustainability Report

NEUCHÂTEL, Switzerland, Jan. 31, 2019 /PRNewswire/ -- MBP Solutions supplies various services. These include by-product and Read more ››

By: PR Newswire Association LLC. - 31 Jan 2019

Sanofi: Fexinidazole, the first all-oral treatment for sleeping sickness, approved in Democratic Republic of Congo

Read more ››
By: Nasdaq / GlobenewsWire - 30 Jan 2019

Therachon Strengthens Board of Directors with the Appointment of Industry Leaders Sandip Kapadia and Patrick Machado

BASEL, Switzerland, Jan. 30, 2019 /PRNewswire/ -- Therachon AG ("Therachon"), a clinical-stage biotechnology company focused on the discovery,... Read more ››

By: PR Newswire Association LLC. - 30 Jan 2019
Related companies:  Therachon AG
«  1  2  3  4  5 6  7  8  9  10  11  12 »

Looking for companies outside of Switzerland?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • April 2019
    • Seoul: BIO KOREA 2019
    • London: BioTrinity 2019
  • May 2019
    • Basel: Swiss Biotech Day
See Events »
Add an Event »

Latest company news

CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Beta Thalassemia
16 Apr 2019 (Nasdaq / GlobenewsWire)

Tessa Therapeutics Announces Collaboration with Merck Investigating the Combination of KEYTRUDA® (pembrolizumab) and Virus-Specific T Cell Therapy Targeting Human Papillomavirus in Cervical Cancer
16 Apr 2019 (PR Newswire Association LLC.)

Auris Medical Receives Positive Nasdaq Listing Determination
15 Apr 2019 (Nasdaq / GlobenewsWire)

Biotechgate database

About Biotechgate
The Swiss Life Sciences Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com